Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Amortization of Deferred Charges (2020 - 2025)

Historic Amortization of Deferred Charges for Aspen Aerogels (ASPN) over the last 8 years, with Q3 2025 value amounting to $951000.0.

  • Aspen Aerogels' Amortization of Deferred Charges rose 21594.68% to $951000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 92796.35%. This contributed to the annual value of $1.1 million for FY2024, which is 297837.84% up from last year.
  • As of Q3 2025, Aspen Aerogels' Amortization of Deferred Charges stood at $951000.0, which was up 21594.68% from $882000.0 recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Amortization of Deferred Charges registered a high of $951000.0 during Q3 2025, and its lowest value of $3000.0 during Q1 2021.
  • In the last 5 years, Aspen Aerogels' Amortization of Deferred Charges had a median value of $9500.0 in 2022 and averaged $210500.0.
  • In the last 5 years, Aspen Aerogels' Amortization of Deferred Charges plummeted by 909.09% in 2022 and then skyrocketed by 900000.0% in 2024.
  • Over the past 5 years, Aspen Aerogels' Amortization of Deferred Charges (Quarter) stood at $11000.0 in 2021, then fell by 18.18% to $9000.0 in 2022, then changed by 0.0% to $9000.0 in 2023, then surged by 9000.0% to $819000.0 in 2024, then increased by 16.12% to $951000.0 in 2025.
  • Its Amortization of Deferred Charges stands at $951000.0 for Q3 2025, versus $882000.0 for Q2 2025 and $730000.0 for Q1 2025.